Sharemaestro Newsreel

Sight Sciences (NASDAQ:SGHT) Rating Increased to Buy at Wall Street Zen

iRhythm Technologies (NASDAQ:IRTC) Rating Lowered to "Hold" at Wall Street Zen

Wall Street Zen has downgraded iRhythm Technologies (NASDAQ:IRTC) to a "Hold" rating from "Buy," despite the company's strong Q2 results and a broader analyst consensus of "Moderate Buy." iRhythm reported earnings of $0.58 per share against an expected loss and saw revenue increase by …

Delcath Systems (NASDAQ:DCTH) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded Delcath Systems (NASDAQ:DCTH) from a "hold" to a "buy" rating, with other analysts maintaining buy ratings and raising price targets, leading to a consensus "Moderate Buy" rating and an average price target of $23.17. The company recently reported strong quarterly …

CVRx (NASDAQ:CVRX) Rating Lowered to Sell at Wall Street Zen

CVRx (NASDAQ:CVRX) has had its rating lowered to "sell" by Wall Street Zen, with several other analysts also reducing their ratings due to concerns about profitability and execution. The company reported a quarterly loss and negative margins, leading to a cut in revenue guidance …

Enterprise value to EBIT forward of Neuropace, Inc. – NASDAQ:NPCE

This article provides a financial data point for Neuropace, Inc. (NASDAQ: NPCE), specifically its enterprise value to EBIT forward. It appears to be a financial snapshot from TradingView, indicating the company's financial metrics. The content is sparse, primarily focusing on this single financial ratio …

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Upgraded to Sell at Wall Street Zen

Wall Street Zen has upgraded Senseonics Holdings, Inc. (NASDAQ:SENS) from "strong sell" to "sell," despite the broader analyst consensus remaining a "Moderate Buy" with a $17.20 price target. The company's shares increased by 36.3% to $7.02, but it reported a wider-than-expected quarterly loss of …

Is Rising Revenue But Weaker Margins Altering The Investment Case For Globus Medical (GMED)?

Globus Medical (GMED) recently reported Q2 2026 results showing increased revenue but decreased net income and diluted EPS, indicating margin compression. While the company reaffirmed its full-year revenue outlook, the focus has shifted to cost control and integration of acquisitions to improve profitability. The …

Pacific Biosciences of California (NASDAQ:PACB) Cut to "Sell" at Wall Street Zen

Wall Street Zen has downgraded Pacific Biosciences of California (NASDAQ:PACB) from a "hold" to a "sell" rating. The company recently missed its quarterly earnings and revenue estimates, reporting a loss of $0.14 per share and $39.01 million in revenue. Analysts currently hold a "Reduce" …

UFP Technologies (NASDAQ:UFPT) Upgraded to Buy at Wall Street Zen

UFP Technologies (NASDAQ:UFPT) was upgraded to a "Buy" rating by Wall Street Zen, though its overall analyst rating remains "Hold" due to Weiss Ratings only slightly increasing its score. The company recently reported strong quarterly earnings, beating both EPS and revenue estimates. Despite recent …

Pulmonx (LUNG) Q2 2026 Earnings Call Transcript

Pulmonx (LUNG) reported its Q2 2026 earnings, highlighting a 34% reduction in net loss and a 39% decrease in adjusted EBITDA loss, driven by cost alignment initiatives. The company reiterated its full-year revenue guidance of $90 million to $92 million and expects to return …

ClearPoint Neuro (NASDAQ:CLPT) Downgraded to "Strong Sell" Rating by Wall Street Zen

Wall Street Zen has downgraded ClearPoint Neuro (NASDAQ:CLPT) to a "strong sell" rating, despite other analysts having a mixed view with a consensus "Hold" rating and a target price of $25.67. The downgrade follows ClearPoint Neuro missing its quarterly earnings expectations, reporting an adjusted …

IMA,CVRX Volatility & Greeks

This article provides detailed financial data and performance metrics for two companies, ImageneBio Inc (IMA) and CVRx Inc (CVRX). It includes information on their stock performance, market capitalization, income, sales, volatility, and various financial ratios, offering a snapshot of their current market standing.

Inogen (INGN) Stock Drops As Guidance Cut Clouds Margin Progress

iRhythm Technologies, Inc. Q2 2026 Earnings Call Summary

iRhythm Technologies reported its seventh consecutive quarter of over 20% revenue growth, driven by strong demand across cardiology, primary care, and international markets. The company announced the acquisition of VitalConnect to expand into new cardiac monitoring modalities and raised its full-year 2026 revenue guidance …

Securities Fraud Investigation Into TriSalus Life Sciences Inc

Glancy Prongay Wolke & Rotter LLP has launched a securities fraud investigation into TriSalus Life Sciences Inc. (NASDAQ: TLSI) on behalf of investors who lost money. The investigation follows a significant drop in TriSalus's stock price after the company reported lower-than-expected Q1 revenues and …

Class Action Lawsuit Filed Against Inspire Medical Systems, Inc

A securities class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) on behalf of investors who purchased securities between August 6, 2024, and August 4, 2025. The lawsuit alleges that Inspire Medical Systems made false statements and concealed critical issues …

Earnings Preview: Beyond Air to Report Financial Results Post-market on August 13

Beyond Air (NASDAQ: XAIR) is scheduled to announce its quarterly financial results after the market closes on August 13, 2026. Analysts are predicting an EPS of -$0.23 for the quarter, with revenue forecasts ranging from $1.3 million to $1.9 million. The report will provide …

Why iRhythm Holdings (IRTC) Is Up 9.1% After Raising 2026 Outlook and Advancing Legal Settlement – And What's Next

In early August 2026, iRhythm Holdings reported second-quarter 2026 results showing sales rising to US$224.17 million and net loss narrowing to US$0.381 million, while also increasing its full-year 2026 revenue guidance to US$880 million–US$890 million and announcing a proposed US$45.00 million securities class action …

CVRx, Inc. Stock 12‑Month Price Target Cut to $8, Implies 35% Upside

CVRx, Inc.'s stock 12-month price target has been lowered from $11.17 to $8, according to estimates from 5 analysts, with a range of $4 to $14 per share. This new target suggests a potential upside of approximately 35% from the August 6 closing price. …

Key facts: CVRx, Inc. Q2 revenue +16%; Humana adds Barostim

CVRx, Inc. (CVRX) reported Q2 revenue of $15.7 million, a 16% increase year-over-year, with U.S. sales up 21% to $14.8 million. The company achieved an 87% gross profit margin, resulting in a net loss of $14.0 million, and holds $64.6 million in cash. Additionally, …

Alphatec Holdings general counsel sells $78,821 in ATEC shares

Tyson Eliot Marshall, General Counsel of Alphatec Holdings (NASDAQ:ATEC), sold 8,168 shares for a total of $78,821 to cover tax withholding obligations from vested restricted stock units. This sale was conducted under a Rule 10b5-1 trading plan. Despite the stock being down 56% year-to-date, …

Law firm probes CVRx over possible securities l...

A law firm is investigating CVRx, Inc. and its executives for potential securities law violations after the company cut its 2026 revenue guidance and disclosed a Department of Justice inquiry. The revenue guidance reduction was attributed to challenges such as high employee turnover, slow …

People on the Move: Heather Getz Joins TELA Bio as Chief Executive Officer

TELA Bio, Inc., a medical technology company, has appointed Heather Getz as its new Chief Executive Officer and Director, effective August 4, 2026. Getz succeeds co-founder Antony Koblish and brings a strong track record of operational excellence and financial transformation from her previous roles …

QuidelOrtho (QDEL) Stock Sinks As Cash Burn And Debt Eclipse Progress

Rapid Micro Biosystems (NASDAQ:RPID) Issues Earnings Results, Misses Estimates By $0.03 EPS

Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates

908 Devices Inc. (MASS) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for 908 Devices Inc. (MASS), highlighting its strong earnings forecast score of 9.20 within the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $10.00, with a consensus "Strong Buy" rating based on 5 …

Delcath Systems (NASDAQ:DCTH) Issues Earnings Results, Beats Estimates By $0.16 EPS

Delcath Systems (NASDAQ:DCTH) reported stronger-than-expected Q2 earnings, with EPS of $0.07 against an estimated loss of $0.09, and revenue reaching $29.13 million, surpassing expectations. The company raised its full-year 2026 revenue guidance to $104 million-$108 million, driven by a 21% year-over-year increase in HEPZATO …

Biomerica Inc (BMRA) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Biomerica Inc (BMRA), focusing on future EPS and revenue growth estimates. It includes a snapshot of the company's current stock price, market capitalization, and a peer comparison with other healthcare equipment and supplies companies. The forecast is …

Apyx Medical Corporation Revenue Breakdown – NASDAQ:APYX

Tandem Diabetes Care (TNDM) Stock Jumps As Margin Recovery Steals The Spotlight

Tandem Diabetes Care's stock surged 19% after its Q2 earnings report, despite a net loss, due to a significant recovery in gross margin to 57%. Revenue grew 6%, and the net loss narrowed by 60%, with strong performance in international pump shipments and an …

Dimensional Fund Advisors LP Sells 6,377 Shares of Glaukos Corporation $GKOS

Dimensional Fund Advisors LP has reduced its stake in Glaukos Corporation (NYSE:GKOS) by 3.1%, selling 6,377 shares and retaining 199,084 shares valued at approximately $21.4 million. Despite this, institutional investors collectively own 99.04% of Glaukos's stock, and analysts maintain a "Moderate Buy" rating with …

CapsoVision Inc (CV) Stock News Today

This article provides an update on CapsoVision Inc (CV) stock, including its current price of $7.100, a 2.90% increase, and a market cap of 353.86M. It indicates that more news, earnings, analyst ratings, and key developments for CapsoVision Inc are expected soon. The page …

LivaNova PLC (LIVN) Stock News Today

IRadimed (IRMD) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Friday, July 31, 2026 at 11:00 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Roger SusiChief Financial Officer - John Glenn TAKEAWAYS Revenue -- $20.5 million, representing a 0.5% increase from $20.4 million in the second …

Enovis (ENOV) Stock Eyes Margin Gains as Free Cash Flow Improves

Enovis (ENOV) stock saw a modest 1.1% increase despite reporting significant improvements in its Q2 financials, including a narrowed net loss, improved gross and EBITDA margins, and positive free cash flow of US$31 million. The company's future prospects hinge on translating operational progress into …